Pharmaceutical for treatment of central nervous system diseases, comprises toll-like receptor ligand and/or Nod2 ligand

摘要

At least one toll-like receptor (TLR) ligand and/or a Nod2 ligand is used for a pharmaceutical for the treatment of diseases affecting the central nervous system. The ligand is selected from the group comprising lipopolysaccharides (LPS), R848, polyinosinic acid-polycytidylic acid, N-acetylmuramyl dipeptide or their derivatives.